Statement Of Income And Retained Earnings

RaQualia Pharma Inc. - Filing #7269486

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-213,383,000 JPY
322,714,000 JPY
-478,408,000 JPY
-337,366,000 JPY
Non-operating income
Non-operating income
67,673,000 JPY
89,524,000 JPY
77,851,000 JPY
88,257,000 JPY
Non-operating expenses
Non-operating expenses
215,802,000 JPY
215,512,000 JPY
44,291,000 JPY
44,291,000 JPY
Ordinary profit (loss)
-361,511,000 JPY
196,726,000 JPY
-444,848,000 JPY
-293,400,000 JPY
Extraordinary income
Extraordinary income
9,379,000 JPY
9,379,000 JPY
JPY
JPY
Extraordinary losses
Extraordinary losses
5,600,000 JPY
5,600,000 JPY
649,000 JPY
649,000 JPY
Profit (loss) before income taxes
-357,732,000 JPY
200,505,000 JPY
-445,497,000 JPY
-294,049,000 JPY
Income taxes - current
119,758,000 JPY
158,988,000 JPY
49,528,000 JPY
93,627,000 JPY
Income taxes - deferred
17,540,000 JPY
-14,686,000 JPY
-64,014,000 JPY
-64,014,000 JPY
Profit (loss)
56,203,000 JPY
JPY
-495,031,000 JPY
56,203,000 JPY
56,203,000 JPY
-431,011,000 JPY
-431,011,000 JPY
-323,662,000 JPY
-431,011,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.